The new tests can open a window into the duration of immunity and to the antibody levels needed to sustain it. But first, a universal standard is needed to ensure results are comparable between tests.
MedCity News
Key takeaways from BioNTech CEO’s JPM presentation Ugur Sahin presented a sweeping vision of the company s goal to become a next-generation immunotherapy company leveraging the messenger RNA platform technology that has won it acclaim and financial returns during the Covid-19 pandemic.
Shares1
As the Covid-19 pandemic continues to wreak havoc in the U.S., the CEO of BioNTech that received the first emergency use authorization for a vaccine presented his vision to transform ther German company into an immunotherapy powerhouse at the all-virtual 39th Annual J.P. Morgan Healthcare Conference. BioNTech and Pfizer jointly received the EUA from the Food and Drug Administration back on Dec. 11.
MedCity News
Northwell offers Whole Foods employees access to primary care services through new partnership
A subsidiary of Northwell Health is partnering with Whole Foods Market to offer its New York-based employees access to seven primary care locations. The supermarket chain s employees will not be subject to a deductible or co-pay.
Shares1
Northwell Direct, a subsidiary of New Hyde Park, New York-based Northwell Health, is partnering with Whole Foods Market to provide its employees in the New York metro area with access to a customized primary care network.
Whole Foods team members will have access to seven Northwell Health primary care locations in Westchester and Long Island as well as in Manhattan and Queens in New York City.
Veeneta Lakhani
Veeneta, SVP of Health Services, Vida Health. is an innovative healthcare executive with a decade of experience in senior-level health plan positions across value-based reimbursement, provider operations, and strategic planning. She was formerly Vice President at Anthem where she led the enterprise-wide rollout of Anthem s ACO program and population health services. She began her career in consulting at Mckinsey and Company where she was an Associate Partner and Accenture where she was in the technology practice.
Some much-needed help: HHS doles out $22B for testing, vaccines
States will get some much needed support to roll out a coronavirus vaccine. Last week, the Department of Health and Human Services shared it would roll out $22 billion in funding to support state testing and vaccination efforts.
Shares0
For months, states warned that additional funding would be needed to distribute a coronavirus vaccine. Last week, they finally got their wish.
The Department of Health and Human Services said it would push out $3 billion to states for vaccine distribution, and another $19 billion for testing before January 19. Both were sorely needed.
While the current administration has kept half of all vaccine doses in reserve to be used for people’s second doses, President-elect Joe Biden said he plans to send most of them out to be used immediately. The bet is that pharmaceutical companies will be able to manufacture enough doses in time for people to receive their booster shot.